epitope requestmappingg 和 epitope binning 的区别

BioonGroup旗下网站
竞争性分析Epitope Mapping实验方法
The simplest way to determine whether two monoclonal antibodies bind to distinct sites on a protein antigen is to carry out a competition assay. The assay can be used with antibodies that bind both conformational and linear epitopes, and it is most useful in the analysis of monoclonal antibody specificity because polyclonal sera typically recognize multiple different epitopes. This simple, ELISA-based protocol examines the ability of two hypothetical, newly derived monoclonal antibodies, XH1 and XH2, to compete with the well-characterized ZO-1 anti-YFP1 antibody for binding to the target antigen YFP1; hypothetical antibody PC10 is used as a control. First, 96-well plates are coated with the YFP1 antigen and direct binding assays are run to determine that all of the antibody preparations are active and able to react with the immobilized antigen. Second, the competition analysis itself is carried out. Note that the names of antibodies and antigens should be considered as generic.
MATERIALS&
Biotin-labeled ZO-1 antibody &
H2SO4 (100 mM)&
NaHCO3 (0.1 M, pH 9.6) (Optional, see Step 1)&
137 mM NaCl
2.7 mM KCl
10 mM Na2HPO4
2 mM KH2HPO4&To prepare 1 liter of PBS (Phosphate-buffered Saline), dissolve 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 0.24 g of KH2HPO4 in 800 ml of distilled H2O. Adjust the pH to 7.4 (or 7.2 if required) with HCl. Add H2O to 1 liter. Dispense the solution into aliquots and sterilize them by autoclaving for 20 minutes at 15 psi (1.05 kg/cm2) on liquid cycle or by filter sterilization. Store the buffer at room temperature. If necessary, PBS may be supplemented with 1 mM CaCl2 and 0.5 mM MgCl2. Can be made as a 10x stock.
PBS with BSA (1% [w/v]; should not contain azide)&
PBS with Tween 20 (0.05%)&
Rabbit anti-mouse IgG peroxidase conjugate&
Streptavidin-peroxidase conjugate&
TMB substrate
3, 3', 5, 5'-tetramethylbenzidine (TMB) (50 g/l stock), 50 &l
Sodium acetate (0.1 M, pH 6.6), 5 ml
Hydrogen peroxide (30%), 1 &l
Prepare fresh before each use.
Unlabeled control monoclonal antibody PC10&
Unlabeled XH1 and XH2 antibodies&
Unlabeled ZO-1 antibody&
YFP1 (the target antigen) &
Equipment&
96-well microtiter plates&
Incubator, preset to 70°C&
Microplate reader&
Determination of Activity and Titer of Test and Control Antibodies&
Prepare a stock solution of YFP1 at 20 &g/ml in NaHCO3 (0.1 M, pH 9.6) or in PBS. Add 50 &l to the wells of a 96-well microtiter plate and incubate for 2 hours at room temperature or overnight at 4°C.&
Wash the wells three times in PBS/Tween (0.05%).&
Fill the wells (200 &l) with PBS/BSA (1%) and incubate at room temperature for 1 hour.&
Wash twice in PBS/Tween (0.05%).&
In a separate 96-well plate, prepare a titration series of the biotin-labeled ZO-1 and the unlabeled ZO-1, XH1, XH2, and control PC10 antibodies over five 10-fold dilutions using PBS/BSA (1%) as a diluent. The starting concentration of the antibody solutions should be about 10 &g/ml. Hybridoma supernatants can be used neat.&
Transfer 50 &l of each dilution onto the antigen-coated plate and incubate for 2 hours at room temperature.&
Wash the plate four times in PBS/Tween (0.05%).&
Add 50 &l of rabbit anti-mouse peroxidase conjugate (diluted 1 in 5000 in PBS/BSA [1%]) to all of the wells containing unlabeled antibody. Add the streptavidin-peroxidase conjugate (diluted 1 in 5000 in PBS/BSA [1%]) to the wells that contain the biotinylated ZO-1 antibody.&
Incubate for 2 hours at room temperature or overnight at 4°C, and then wash the plate four times in PBS/Tween (0.05%).&
Add 50 &l of freshly prepared TMB substrate to each test well and incubate at room temperature for 5-15 minutes as the blue color develops in the wells containing the highest concentration of specific antibody.&
After development of the blue color, stop the reaction by adding 50 &l of 100 mM H2SO4. Determine the absorbance of the now-yellow product read at 450-nm wavelength in a microplate reader. The positive antibodies should give a strong, clear signal that diminishes through the latter part of the dilution series. This establishes that the specific unlabeled antibodies are able to bind to the target antigen, identifies those having very weak activity, and establishes a suitable concentration of labeled antibody to use in the competition assay. &The Competition Assay&
Prepare antigen-coated plates as in Steps 1-4 above. The assay can be configured in a large number of different formats using either labeled antigen or labeled antibody. The key requirements remain the same, however-a demonstration that all of the antibodies are able to bind the test antigen in the assay and the labeling of one of the antibodies that allows it to be distinguished from the competitor antibody. Commonly, the antigen is immobilized on a 96-well plate. Some antigens are partially denatured on absorption to plastic, and in these cases, alternate means of immobilizing the antigen may be explored. &
Incubate the wells with the dilution series of unlabeled antibodies as above for 2 hours at room temperature.&
Without washing the wells, add 50 &l of the dilution of the biotin-labeled ZO-1 antibody that gave the strongest signal before the next point in the titration curve showing a strongly reduced signal, as determined in the previous procedure.&
Wash the plate four times in PBS/Tween (0.05%).&
Add streptavidin-peroxidase conjugate (diluted 1 in 5000 in PBS/BSA (1%)) to all of the wells.&
Incubate for 2 hours at room temperature or overnight at 4°C, and then wash the plate four times in PBS/Tween (0.05%).&
Add 50 &l of freshly prepared TMB substrate to each test well and incubate at room temperature for 5-15 minutes. The blue color develops in the wells containing the highest concentration of specific antibody.&
After development of the blue color, stop the reaction by adding 50 &l of H2SO4 (100 mM). Determine the absorbance of the now-yellow product read at 450-nm wavelength in a microplate reader.&A strong reduction in the signal of the binding of the labeled ZO-1 should be seen by the highest concentrations of the unlabeled ZO-1 (homotypic competition). The control PC10 antibody should not inhibit the signal at any concentration. Results for the newly derived XH1 and XH2 antibodies should be interpreted carefully. If, for example, the novel competing antibody XH2 reduces the signal, whereas the other new antibody XH1 does not, then it may be concluded that XH2 and ZO-1 recognize sterically competitive epitopes, whereas the XH1 epitope is clearly unique. &
Anyone using the procedures in this protocol does so at their own risk. Cold Spring Harbor Laboratory makes no representations or warranties with respect to the material set forth in this protocol and has no liability in connection with the use of these materials. Materials used in this protocol may be considered hazardous and should be used with caution. For a full listing of cautions regarding these material, please consult: Using Antibodies: A Laboratory Manual, by Ed Harlow and David Lane, & 1999 by Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, p. 386-389.
相关基因组作图实验epitope mapping
单抗抗原表位鉴定
抗原表位定位
In a report to be published in the latest issue of Nature Medicine online Oct. 31, researchers describe a new "epitope-mapping" laboratory test that within three weeks can pinpoint the unique binding site -- or epitope -- from any antigen where immune system T cells can most securely attach and attack invading germs or errant cells.
基于1个网页-
四聚体表位作图技术
细胞肽表位
- 引用次数:2
参考来源 - SARS病毒S蛋白特异性单克隆抗体制备和抗原识别位点鉴定
&2,447,543篇论文数据,部分数据来源于
Epitope mapping
Epitope mapping is the process of identifying the binding sites, or ‘epitopes’, of antibodies on their target antigens (which are proteins).
以上来源于:
The method based on expressed peptide for mapping epitope on viral prot…
实验表明,用基因工程表达的多肽筛选抗原表位的方法是可行的。
A novel method was designed for disease specific B cell epitope mapping and epitope expression in E.
设计了一种新的病原体蛋白质B细胞抗原表位的筛选和重组表达方法。
This paper reviews the applications of the aforementioned epitope mapping technologies in epitope prediction and research progresses on epitope prediction.
本文将对新的表位定位技术在表位定位中的应用、表位预测以及相关应用进展进行阐述。
$firstVoiceSent
- 来自原声例句
请问您想要如何调整此模块?
感谢您的反馈,我们会尽快进行适当修改!
请问您想要如何调整此模块?
感谢您的反馈,我们会尽快进行适当修改!epitope mapping protocol_百度文库
两大类热门资源免费畅读
续费一年阅读会员,立省24元!
epitope mapping protocol
阅读已结束,下载文档到电脑
想免费下载更多文档?
定制HR最喜欢的简历
下载文档到电脑,方便使用
还剩55页未读,继续阅读
定制HR最喜欢的简历
你可能喜欢 上传我的文档
 下载
 收藏
该文档贡献者很忙,什么也没留下。
 下载此文档
正在努力加载中...
expanding the proteon xpr36 biosensor into a 36-ligand :的质子xpr36扩大成36配体的.
下载积分:1500
内容提示:expanding the proteon xpr36 biosensor into a 36-ligand :的质子xpr36扩大成36配体的生物传感器
文档格式:PDF|
浏览次数:0|
上传日期: 08:33:24|
文档星级:
全文阅读已结束,如果下载本文需要使用
 1500 积分
下载此文档
该用户还上传了这些文档
expanding the proteon xpr36 biosensor into a 36-li
关注微信公众号}

我要回帖

更多关于 mapping 的文章

更多推荐

版权声明:文章内容来源于网络,版权归原作者所有,如有侵权请点击这里与我们联系,我们将及时删除。

点击添加站长微信